Scotia Capital Inc. Oncolytics Biotech Inc Transaction History

Scotia Capital Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$1.22 - $2.09 $13,028 - $22,319	10,679 New	10,679 $14,000
Q2 2020 Aug 11, 2020	SELL	$1.33 - $2.76 $62,811 - $130,346	-47,227 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$0.42 - $4.76 $341 - $3,865	-812 Reduced 1.69%	47,227 $223,000
Q2 2019 Aug 13, 2019	BUY	$1.63 - $1.95 $5,426 - $6,491	3,329 Added 7.45%	48,039 $83,000
Q1 2019 May 15, 2019	BUY	$1.77 - $2.31 $391 - $510	221 Added 0.5%	44,710 $82,000
Q4 2018 Feb 11, 2019	BUY	$1.72 - $4.12 $76,521 - $183,294	44,489 New	44,489 $80,000

1.18M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $49.2M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Scotia Capital Inc. with notifications on news.